Cargando…
Plasmodium falciparum Thioredoxin Reductase (PfTrxR) and Its Role as a Target for New Antimalarial Discovery
The growing resistance to current antimalarial drugs is a major concern for global public health. The pressing need for new antimalarials has led to an increase in research focused on the Plasmodium parasites that cause human malaria. Thioredoxin reductase (TrxR), an enzyme needed to maintain redox...
Autores principales: | McCarty, Sara E., Schellenberger, Amanda, Goodwin, Douglas C., Fuanta, Ngolui Rene, Tekwani, Babu L., Calderón, Angela I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272602/ https://www.ncbi.nlm.nih.gov/pubmed/26111176 http://dx.doi.org/10.3390/molecules200611459 |
Ejemplares similares
-
Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques
por: Munigunti, Ranjith, et al.
Publicado: (2013) -
Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box
por: Tiwari, Neil K., et al.
Publicado: (2016) -
Identification and Functional Validation of the Novel Antimalarial
Resistance Locus PF10_0355 in Plasmodium
falciparum
por: Van Tyne, Daria, et al.
Publicado: (2011) -
A Mechanistic Investigation of the C-Terminal Redox Motif of Thioredoxin Reductase from Plasmodium falciparum
por: Snider, Gregg W., et al.
Publicado: (2014) -
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
por: Ross, Leila S., et al.
Publicado: (2018)